Ofman is responsible for directing Amgen activities related to ensuring that Amgen products have a compelling value proposition and obtain market access from payers in each market, worldwide. These activities include global pricing, market access planning, global health economics, international government affairs, and health policy. Prior to joining Amgen in 2003 as head of U.S. Health Economics and Outcomes Research, Ofman was a member of the academic faculty in the Department of Medicine and Health Services Research, UCLA School of Medicine, Cedars-Sinai Medical Center. In this capacity, Ofman worked extensively with the Agency for Healthcare Research and Quality’s Southern California Evidence-Based Practice Center and taught courses on the principles of evidence-based medicine. Ofman also served as the senior vice president of Zynx Health Inc., a consulting company focused on evidence-based clinical information for quality improvement, and reimbursement and health economics strategy for life sciences companies. Ofman received his undergraduate degree in the history and philosophy of science at University of California, Berkeley before completing his medical education at UC Irvine School of Medicine. Following an internship and residency in internal medicine at UCLA Medical Center residency, Ofman completed a two-year VA/UCLA/RAND fellowship in health services research, during which time he received his Masters of Science in Health Services (MSHS) degree from the UCLA School of Public Health.
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biom
Copyright©2012 Vocus, Inc.
All rights reserved